The global Drug Eluting Balloon for Peripheral Artery Disease market was valued at US$ 811 million in 2025 and is anticipated to reach US$ 1775 million by 2032, at a CAGR of 11.7% from 2026 to 2032.

Drug Eluting Balloon for Peripheral Artery Disease Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Drug Eluting Balloon for Peripheral Artery Disease competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Drug-eluting/drug-coated balloons (DEB/DCB) for peripheral artery disease (PAD) are angioplasty balloons coated with an antiproliferative drug (predominantly paclitaxel, with ongoing “limus” exploration) plus an excipient/carrier matrix. During inflation, they deliver mechanical lumen gain while rapidly transferring drug into the vessel wall to suppress neointimal hyperplasia and reduce restenosis and repeat interventions. Centered on a “leave nothing behind” concept, PAD-focused DCBs aim to preserve future treatment flexibility while improving durability—often used in conjunction with lesion preparation (plaque modification, scoring/cutting balloons) and intravascular imaging (e.g., IVUS) to enable more refined and repeatable peripheral vascular repair.In 2025, global Drug Eluting Balloon for Peripheral Artery Disease production reached approximately 773 k units and price is 1048 USD/Unit.The average gross profit margin of this product is 73%.

PAD care continues to shift toward minimally invasive, repair-centric strategies, and DCBs address a core clinical pain point: durable patency with reduced stent burden and fewer reinterventions. Importantly, the safety boundary has become clearer. In July 2023, the U.S. FDA updated its communication stating that the totality of available evidence does not indicate an excess late mortality risk for paclitaxel-coated devices in PAD—supporting more predictable hospital governance and pathway adoption. In parallel, leading medtech companies have highlighted drug-coated balloons as a contributor to peripheral interventions momentum in annual reporting, signaling a transition from selective use toward routine toolset adoption.

The hurdle is no longer “can you launch,” but “can you scale with reproducibility and compliant delivery.” As drug–device combination products, DCBs are highly sensitive to coating integrity, particulate control, batch-to-batch dose consistency, and shelf-life stability—where process drift can translate into outsized clinical reputation and access risk. Meanwhile, cost-containment intensifies the need to balance quality systems, supply assurance, and manufacturing efficiency. In China, drug-coated balloons have been included in national centralized procurement with publicly announced results, accelerating a more rules-based and scale-driven competitive phase. Brokerage commentary broadly notes that procurement reforms can standardize purchasing and usage and improve market order, while near-term price pressure forces value to be rebuilt through efficiency and differentiated evidence.

Demand is consolidating around repeatable techniques and bundled solutions. High recurrence and reintervention sensitivity in PAD elevate integrated optimization—lesion preparation, drug-transfer efficiency, and durable patency—driving more routine combination of DCBs with plaque-modification tools, specialty scoring/cutting balloons, and intravascular imaging (e.g., IVUS). Under tighter compliance and procurement frameworks, hospitals increasingly formalize device bundles and clinical pathways, shifting adoption from “operator preference–driven” toward “pathway management–driven” growth—where evidence communication, technique standardization, and supply reliability matter more than ever.

Upstream differentiation is ultimately an integrated “materials–coating–validation” capability rather than a simple bill of materials. Key inputs include balloon/catheter polymers and reinforcements (films, multi-durometer shafts, liners, braids/coils), drug APIs (paclitaxel or “limus” agents) with excipient/carrier systems, coating solvents and metrology consumables, lubricious/hydrophilic surface coatings, plus sterile barrier packaging and sterilization services. As regulatory scrutiny, centralized procurement fulfillment, and global compliance advance in parallel, medical-grade traceability, robust change control, and clean manufacturing at the supplier level directly shape yield, release consistency, and long-term commercial credibility.

This report delivers a comprehensive overview of the global Drug Eluting Balloon for Peripheral Artery Disease market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Drug Eluting Balloon for Peripheral Artery Disease. The Drug Eluting Balloon for Peripheral Artery Disease market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Drug Eluting Balloon for Peripheral Artery Disease market comprehensively. Regional market sizes by Type, by Application, by Use Scenario, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Drug Eluting Balloon for Peripheral Artery Disease manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Drug Eluting Balloon for Peripheral Artery Disease Market Report

Report Metric	Details
Report Name	Drug Eluting Balloon for Peripheral Artery Disease Market
Accounted market size in 2025	US$ 811 million
Forecasted market size in 2032	US$ 1775 million
CAGR	11.7%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Iliac Artery Femoropopliteal Other
Segment by Use Scenario	In-Stent Restenosi De Novo Small Vessel
Segment by Balloon Platform Mechanics	Semi-/Compliant Non-compliant Other
by Application	Hospitals Ambulatory Surgery Centers Catheterization Laboratories Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Medtronic, Boston Scientific, BD, Acotec, Philips, Lepu Medical, Eurocor, MicroPort Medical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Use Scenario, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Drug Eluting Balloon for Peripheral Artery Disease manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Drug Eluting Balloon for Peripheral Artery Disease sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Drug Eluting Balloon for Peripheral Artery Disease Market growing?

Ans: The Drug Eluting Balloon for Peripheral Artery Disease Market witnessing a CAGR of 11.7% during the forecast period 2026-2032.

What is the Drug Eluting Balloon for Peripheral Artery Disease Market size in 2032?

Ans: The Drug Eluting Balloon for Peripheral Artery Disease Market size in 2032 will be US$ 1775 million.

Who are the main players in the Drug Eluting Balloon for Peripheral Artery Disease Market report?

Ans: The main players in the Drug Eluting Balloon for Peripheral Artery Disease Market are Medtronic, Boston Scientific, BD, Acotec, Philips, Lepu Medical, Eurocor, MicroPort Medical

What are the Application segmentation covered in the Drug Eluting Balloon for Peripheral Artery Disease Market report?

Ans: The Applications covered in the Drug Eluting Balloon for Peripheral Artery Disease Market report are Hospitals, Ambulatory Surgery Centers, Catheterization Laboratories, Others

What are the Type segmentation covered in the Drug Eluting Balloon for Peripheral Artery Disease Market report?

Ans: The Types covered in the Drug Eluting Balloon for Peripheral Artery Disease Market report are Iliac Artery, Femoropopliteal, Other

1 Drug Eluting Balloon for Peripheral Artery Disease Market Overview

1.1 Product Definition

1.2 Drug Eluting Balloon for Peripheral Artery Disease by Type

1.2.1 Global Drug Eluting Balloon for Peripheral Artery Disease Market Value by Type: 2025 vs 2032

1.2.2 Iliac Artery

1.2.3 Femoropopliteal

1.2.4 Other

1.3 Drug Eluting Balloon for Peripheral Artery Disease by Use Scenario

1.3.1 Global Drug Eluting Balloon for Peripheral Artery Disease Market Value by Use Scenario: 2025 vs 2032

1.3.2 In-Stent Restenosi

1.3.3 De Novo

1.3.4 Small Vessel

1.4 Drug Eluting Balloon for Peripheral Artery Disease by Balloon Platform Mechanics

1.4.1 Global Drug Eluting Balloon for Peripheral Artery Disease Market Value by Balloon Platform Mechanics: 2025 vs 2032

1.4.2 Semi-/Compliant

1.4.3 Non-compliant

1.4.4 Other

1.5 Drug Eluting Balloon for Peripheral Artery Disease by Application

1.5.1 Global Drug Eluting Balloon for Peripheral Artery Disease Market Value by Application: 2025 vs 2032

1.5.2 Hospitals

1.5.3 Ambulatory Surgery Centers

1.5.4 Catheterization Laboratories

1.5.5 Others

1.6 Global Drug Eluting Balloon for Peripheral Artery Disease Market Size Estimates and Forecasts

1.6.1 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue 2021–2032

1.6.2 Global Drug Eluting Balloon for Peripheral Artery Disease Sales 2021–2032

1.6.3 Global Drug Eluting Balloon for Peripheral Artery Disease Market Average Price (2021–2032)

1.7 Assumptions and Limitations

2 Drug Eluting Balloon for Peripheral Artery Disease Market Competition by Manufacturers

2.1 Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Manufacturers (2021–2026)

2.2 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Drug Eluting Balloon for Peripheral Artery Disease Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Drug Eluting Balloon for Peripheral Artery Disease, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Drug Eluting Balloon for Peripheral Artery Disease, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Drug Eluting Balloon for Peripheral Artery Disease, Product Types and Applications

2.7 Global Key Manufacturers of Drug Eluting Balloon for Peripheral Artery Disease, Date of Entry into the Industry

2.8 Global Drug Eluting Balloon for Peripheral Artery Disease Market Competitive Situation and Trends

2.8.1 Global Drug Eluting Balloon for Peripheral Artery Disease Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Drug Eluting Balloon for Peripheral Artery Disease Players Market Share by Revenue

2.8.3 Global Drug Eluting Balloon for Peripheral Artery Disease Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Drug Eluting Balloon for Peripheral Artery Disease Market Scenario by Region

3.1 Global Drug Eluting Balloon for Peripheral Artery Disease Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Drug Eluting Balloon for Peripheral Artery Disease Sales by Region: 2021–2032

3.2.1 Global Drug Eluting Balloon for Peripheral Artery Disease Sales by Region: 2021–2026

3.2.2 Global Drug Eluting Balloon for Peripheral Artery Disease Sales by Region: 2027–2032

3.3 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue by Region: 2021–2032

3.3.1 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue by Region: 2021–2026

3.3.2 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue by Region: 2027–2032

3.4 North America Drug Eluting Balloon for Peripheral Artery Disease Market Facts & Figures by Country

3.4.1 North America Drug Eluting Balloon for Peripheral Artery Disease Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Drug Eluting Balloon for Peripheral Artery Disease Sales by Country (2021–2032)

3.4.3 North America Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country (2021–2032)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Drug Eluting Balloon for Peripheral Artery Disease Market Facts & Figures by Country

3.5.1 Europe Drug Eluting Balloon for Peripheral Artery Disease Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Drug Eluting Balloon for Peripheral Artery Disease Sales by Country (2021–2032)

3.5.3 Europe Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Drug Eluting Balloon for Peripheral Artery Disease Market Facts & Figures by Region

3.6.1 Asia Pacific Drug Eluting Balloon for Peripheral Artery Disease Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Drug Eluting Balloon for Peripheral Artery Disease Sales by Region (2021–2032)

3.6.3 Asia Pacific Drug Eluting Balloon for Peripheral Artery Disease Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Drug Eluting Balloon for Peripheral Artery Disease Market Facts & Figures by Country

3.7.1 Latin America Drug Eluting Balloon for Peripheral Artery Disease Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Drug Eluting Balloon for Peripheral Artery Disease Sales by Country (2021–2032)

3.7.3 Latin America Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Drug Eluting Balloon for Peripheral Artery Disease Market Facts & Figures by Country

3.8.1 Middle East and Africa Drug Eluting Balloon for Peripheral Artery Disease Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Drug Eluting Balloon for Peripheral Artery Disease Sales by Country (2021–2032)

3.8.3 Middle East and Africa Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Drug Eluting Balloon for Peripheral Artery Disease Sales by Type (2021–2032)

4.1.1 Global Drug Eluting Balloon for Peripheral Artery Disease Sales by Type (2021–2026)

4.1.2 Global Drug Eluting Balloon for Peripheral Artery Disease Sales by Type (2027–2032)

4.1.3 Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Type (2021–2032)

4.2 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue by Type (2021–2032)

4.2.1 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue by Type (2021–2026)

4.2.2 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue by Type (2027–2032)

4.2.3 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Type (2021–2032)

4.3 Global Drug Eluting Balloon for Peripheral Artery Disease Price by Type (2021–2032)

5 Segment by Application

5.1 Global Drug Eluting Balloon for Peripheral Artery Disease Sales by Application (2021–2032)

5.1.1 Global Drug Eluting Balloon for Peripheral Artery Disease Sales by Application (2021–2026)

5.1.2 Global Drug Eluting Balloon for Peripheral Artery Disease Sales by Application (2027–2032)

5.1.3 Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Application (2021–2032)

5.2 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue by Application (2021–2032)

5.2.1 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue by Application (2021–2026)

5.2.2 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue by Application (2027–2032)

5.2.3 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Application (2021–2032)

5.3 Global Drug Eluting Balloon for Peripheral Artery Disease Price by Application (2021–2032)

6 Key Companies Profiled

6.1 Medtronic

6.1.1 Medtronic Company Information

6.1.2 Medtronic Description and Business Overview

6.1.3 Medtronic Drug Eluting Balloon for Peripheral Artery Disease Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 Medtronic Drug Eluting Balloon for Peripheral Artery Disease Product Portfolio

6.1.5 Medtronic Recent Developments/Updates

6.2 Boston Scientific

6.2.1 Boston Scientific Company Information

6.2.2 Boston Scientific Description and Business Overview

6.2.3 Boston Scientific Drug Eluting Balloon for Peripheral Artery Disease Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 Boston Scientific Drug Eluting Balloon for Peripheral Artery Disease Product Portfolio

6.2.5 Boston Scientific Recent Developments/Updates

6.3 BD

6.3.1 BD Company Information

6.3.2 BD Description and Business Overview

6.3.3 BD Drug Eluting Balloon for Peripheral Artery Disease Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 BD Drug Eluting Balloon for Peripheral Artery Disease Product Portfolio

6.3.5 BD Recent Developments/Updates

6.4 Acotec

6.4.1 Acotec Company Information

6.4.2 Acotec Description and Business Overview

6.4.3 Acotec Drug Eluting Balloon for Peripheral Artery Disease Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 Acotec Drug Eluting Balloon for Peripheral Artery Disease Product Portfolio

6.4.5 Acotec Recent Developments/Updates

6.5 Philips

6.5.1 Philips Company Information

6.5.2 Philips Description and Business Overview

6.5.3 Philips Drug Eluting Balloon for Peripheral Artery Disease Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 Philips Drug Eluting Balloon for Peripheral Artery Disease Product Portfolio

6.5.5 Philips Recent Developments/Updates

6.6 Lepu Medical

6.6.1 Lepu Medical Company Information

6.6.2 Lepu Medical Description and Business Overview

6.6.3 Lepu Medical Drug Eluting Balloon for Peripheral Artery Disease Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 Lepu Medical Drug Eluting Balloon for Peripheral Artery Disease Product Portfolio

6.6.5 Lepu Medical Recent Developments/Updates

6.7 Eurocor

6.7.1 Eurocor Company Information

6.7.2 Eurocor Description and Business Overview

6.7.3 Eurocor Drug Eluting Balloon for Peripheral Artery Disease Sales, Revenue, and Gross Margin (2021–2026)

6.7.4 Eurocor Drug Eluting Balloon for Peripheral Artery Disease Product Portfolio

6.7.5 Eurocor Recent Developments/Updates

6.8 MicroPort Medical

6.8.1 MicroPort Medical Company Information

6.8.2 MicroPort Medical Description and Business Overview

6.8.3 MicroPort Medical Drug Eluting Balloon for Peripheral Artery Disease Sales, Revenue, and Gross Margin (2021–2026)

6.8.4 MicroPort Medical Drug Eluting Balloon for Peripheral Artery Disease Product Portfolio

6.8.5 MicroPort Medical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Drug Eluting Balloon for Peripheral Artery Disease Industry Chain Analysis

7.2 Drug Eluting Balloon for Peripheral Artery Disease Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Drug Eluting Balloon for Peripheral Artery Disease Production Mode & Process Analysis

7.4 Drug Eluting Balloon for Peripheral Artery Disease Sales and Marketing

7.4.1 Drug Eluting Balloon for Peripheral Artery Disease Sales Channels

7.4.2 Drug Eluting Balloon for Peripheral Artery Disease Distributors

7.5 Drug Eluting Balloon for Peripheral Artery Disease Customer Analysis

8 Drug Eluting Balloon for Peripheral Artery Disease Market Dynamics

8.1 Drug Eluting Balloon for Peripheral Artery Disease Industry Trends

8.2 Drug Eluting Balloon for Peripheral Artery Disease Market Drivers

8.3 Drug Eluting Balloon for Peripheral Artery Disease Market Challenges

8.4 Drug Eluting Balloon for Peripheral Artery Disease Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Drug Eluting Balloon for Peripheral Artery Disease Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Drug Eluting Balloon for Peripheral Artery Disease Market Value by Use Scenario (US$ Million), 2025 vs 2032

Table 3. Global Drug Eluting Balloon for Peripheral Artery Disease Market Value by Balloon Platform Mechanics (US$ Million), 2025 vs 2032

Table 4. Global Drug Eluting Balloon for Peripheral Artery Disease Market Value by Application (US$ Million), 2025 vs 2032

Table 5. Global Drug Eluting Balloon for Peripheral Artery Disease Market Competitive Situation by Manufacturers in 2025

Table 6. Global Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units) of Key Manufacturers (2021–2026)

Table 7. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Manufacturers (2021–2026)

Table 8. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue (US$ Million) by Manufacturers (2021–2026)

Table 9. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Share by Manufacturers (2021–2026)

Table 10. Global Market Drug Eluting Balloon for Peripheral Artery Disease Average Price (USD/Unit) of Key Manufacturers (2021–2026)

Table 11. Global Key Players of Drug Eluting Balloon for Peripheral Artery Disease, Industry Ranking, 2023 vs 2024 vs 2025

Table 12. Global Key Manufacturers of Drug Eluting Balloon for Peripheral Artery Disease, Manufacturing Sites and Headquarters

Table 13. Global Key Manufacturers of Drug Eluting Balloon for Peripheral Artery Disease, Product Types and Applications

Table 14. Global Key Manufacturers of Drug Eluting Balloon for Peripheral Artery Disease, Date of Entry into the Industry

Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 16. Global Drug Eluting Balloon for Peripheral Artery Disease Companies by Tier (Tier 1, Tier 2, Tier 3), based on Drug Eluting Balloon for Peripheral Artery Disease Revenue, 2025

Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 18. Global Drug Eluting Balloon for Peripheral Artery Disease Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 19. Global Drug Eluting Balloon for Peripheral Artery Disease Sales by Region (K Units), 2021–2026

Table 20. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Region (2021–2026)

Table 21. Global Drug Eluting Balloon for Peripheral Artery Disease Sales by Region (K Units), 2027–2032

Table 22. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Region (2027–2032)

Table 23. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue by Region (US$ Million), 2021–2026

Table 24. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Region (2021–2026)

Table 25. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue by Region (US$ Million), 2027–2032

Table 26. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Region (2027–2032)

Table 27. North America Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 28. North America Drug Eluting Balloon for Peripheral Artery Disease Sales by Country (K Units), 2021–2026

Table 29. North America Drug Eluting Balloon for Peripheral Artery Disease Sales by Country (K Units), 2027–2032

Table 30. North America Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country (US$ Million), 2021–2026

Table 31. North America Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country (US$ Million), 2027–2032

Table 32. Europe Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 33. Europe Drug Eluting Balloon for Peripheral Artery Disease Sales by Country (K Units), 2021–2026

Table 34. Europe Drug Eluting Balloon for Peripheral Artery Disease Sales by Country (K Units), 2027–2032

Table 35. Europe Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country (US$ Million), 2021–2026

Table 36. Europe Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country (US$ Million), 2027–2032

Table 37. Asia Pacific Drug Eluting Balloon for Peripheral Artery Disease Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 38. Asia Pacific Drug Eluting Balloon for Peripheral Artery Disease Sales by Region (K Units), 2021–2026

Table 39. Asia Pacific Drug Eluting Balloon for Peripheral Artery Disease Sales by Region (K Units), 2027–2032

Table 40. Asia Pacific Drug Eluting Balloon for Peripheral Artery Disease Revenue by Region (US$ Million), 2021–2026

Table 41. Asia Pacific Drug Eluting Balloon for Peripheral Artery Disease Revenue by Region (US$ Million), 2027–2032

Table 42. Latin America Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 43. Latin America Drug Eluting Balloon for Peripheral Artery Disease Sales by Country (K Units), 2021–2026

Table 44. Latin America Drug Eluting Balloon for Peripheral Artery Disease Sales by Country (K Units), 2027–2032

Table 45. Latin America Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country (US$ Million), 2021–2026

Table 46. Latin America Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country (US$ Million), 2027–2032

Table 47. Middle East and Africa Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 48. Middle East and Africa Drug Eluting Balloon for Peripheral Artery Disease Sales by Country (K Units), 2021–2026

Table 49. Middle East and Africa Drug Eluting Balloon for Peripheral Artery Disease Sales by Country (K Units), 2027–2032

Table 50. Middle East and Africa Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country (US$ Million), 2021–2026

Table 51. Middle East and Africa Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country (US$ Million), 2027–2032

Table 52. Global Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units) by Type (2021–2026)

Table 53. Global Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units) by Type (2027–2032)

Table 54. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Type (2021–2026)

Table 55. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Type (2027–2032)

Table 56. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue (US$ Million) by Type (2021–2026)

Table 57. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue (US$ Million) by Type (2027–2032)

Table 58. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Type (2021–2026)

Table 59. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Type (2027–2032)

Table 60. Global Drug Eluting Balloon for Peripheral Artery Disease Price (USD/Unit) by Type (2021–2026)

Table 61. Global Drug Eluting Balloon for Peripheral Artery Disease Price (USD/Unit) by Type (2027–2032)

Table 62. Global Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units) by Application (2021–2026)

Table 63. Global Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units) by Application (2027–2032)

Table 64. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Application (2021–2026)

Table 65. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Application (2027–2032)

Table 66. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue (US$ Million) by Application (2021–2026)

Table 67. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue (US$ Million) by Application (2027–2032)

Table 68. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Application (2021–2026)

Table 69. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Application (2027–2032)

Table 70. Global Drug Eluting Balloon for Peripheral Artery Disease Price (USD/Unit) by Application (2021–2026)

Table 71. Global Drug Eluting Balloon for Peripheral Artery Disease Price (USD/Unit) by Application (2027–2032)

Table 72. Medtronic Company Information

Table 73. Medtronic Description and Business Overview

Table 74. Medtronic Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)

Table 75. Medtronic Drug Eluting Balloon for Peripheral Artery Disease Product

Table 76. Medtronic Recent Developments/Updates

Table 77. Boston Scientific Company Information

Table 78. Boston Scientific Description and Business Overview

Table 79. Boston Scientific Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)

Table 80. Boston Scientific Drug Eluting Balloon for Peripheral Artery Disease Product

Table 81. Boston Scientific Recent Developments/Updates

Table 82. BD Company Information

Table 83. BD Description and Business Overview

Table 84. BD Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)

Table 85. BD Drug Eluting Balloon for Peripheral Artery Disease Product

Table 86. BD Recent Developments/Updates

Table 87. Acotec Company Information

Table 88. Acotec Description and Business Overview

Table 89. Acotec Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)

Table 90. Acotec Drug Eluting Balloon for Peripheral Artery Disease Product

Table 91. Acotec Recent Developments/Updates

Table 92. Philips Company Information

Table 93. Philips Description and Business Overview

Table 94. Philips Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)

Table 95. Philips Drug Eluting Balloon for Peripheral Artery Disease Product

Table 96. Philips Recent Developments/Updates

Table 97. Lepu Medical Company Information

Table 98. Lepu Medical Description and Business Overview

Table 99. Lepu Medical Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)

Table 100. Lepu Medical Drug Eluting Balloon for Peripheral Artery Disease Product

Table 101. Lepu Medical Recent Developments/Updates

Table 102. Eurocor Company Information

Table 103. Eurocor Description and Business Overview

Table 104. Eurocor Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)

Table 105. Eurocor Drug Eluting Balloon for Peripheral Artery Disease Product

Table 106. Eurocor Recent Developments/Updates

Table 107. MicroPort Medical Company Information

Table 108. MicroPort Medical Description and Business Overview

Table 109. MicroPort Medical Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)

Table 110. MicroPort Medical Drug Eluting Balloon for Peripheral Artery Disease Product

Table 111. MicroPort Medical Recent Developments/Updates

Table 112. Key Raw Materials Lists

Table 113. Raw Materials Key Suppliers Lists

Table 114. Drug Eluting Balloon for Peripheral Artery Disease Distributors List

Table 115. Drug Eluting Balloon for Peripheral Artery Disease Customers List

Table 116. Drug Eluting Balloon for Peripheral Artery Disease Market Trends

Table 117. Drug Eluting Balloon for Peripheral Artery Disease Market Drivers

Table 118. Drug Eluting Balloon for Peripheral Artery Disease Market Challenges

Table 119. Drug Eluting Balloon for Peripheral Artery Disease Market Restraints

Table 120. Research Programs/Design for This Report

Table 121. Key Data Information from Secondary Sources

Table 122. Key Data Information from Primary Sources

Table 123. Authors List of This Report

List of Figures

Figure 1. Product Picture of Drug Eluting Balloon for Peripheral Artery Disease

Figure 2. Global Drug Eluting Balloon for Peripheral Artery Disease Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Drug Eluting Balloon for Peripheral Artery Disease Market Share by Type: 2025 & 2032

Figure 4. Iliac Artery Product Picture

Figure 5. Femoropopliteal Product Picture

Figure 6. Other Product Picture

Figure 7. Global Drug Eluting Balloon for Peripheral Artery Disease Market Value by Use Scenario (US$ Million), 2021–2032

Figure 8. Global Drug Eluting Balloon for Peripheral Artery Disease Market Share by Use Scenario: 2025 vs 2032

Figure 9. In-Stent Restenosi Product Picture

Figure 10. De Novo Product Picture

Figure 11. Small Vessel Product Picture

Figure 12. Global Drug Eluting Balloon for Peripheral Artery Disease Market Value by Balloon Platform Mechanics (US$ Million), 2021–2032

Figure 13. Global Drug Eluting Balloon for Peripheral Artery Disease Market Share by Balloon Platform Mechanics: 2025 vs 2032

Figure 14. Semi-/Compliant Product Picture

Figure 15. Non-compliant Product Picture

Figure 16. Other Product Picture

Figure 17. Global Drug Eluting Balloon for Peripheral Artery Disease Market Value by Application (US$ Million), 2021–2032

Figure 18. Global Drug Eluting Balloon for Peripheral Artery Disease Market Share by Application: 2025 & 2032

Figure 19. Hospitals

Figure 20. Ambulatory Surgery Centers

Figure 21. Catheterization Laboratories

Figure 22. Others

Figure 23. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 24. Global Drug Eluting Balloon for Peripheral Artery Disease Market Size (US$ Million), 2021–2032

Figure 25. Global Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units), 2021–2032

Figure 26. Global Drug Eluting Balloon for Peripheral Artery Disease Average Price (USD/Unit), 2021–2032

Figure 27. Drug Eluting Balloon for Peripheral Artery Disease Report Years Considered

Figure 28. Drug Eluting Balloon for Peripheral Artery Disease Sales Share by Manufacturers in 2025

Figure 29. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Share by Manufacturers in 2025

Figure 30. Top 5 and Top 10 Global Drug Eluting Balloon for Peripheral Artery Disease Players: Market Share by Revenue in Drug Eluting Balloon for Peripheral Artery Disease in 2025

Figure 31. Drug Eluting Balloon for Peripheral Artery Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 32. Global Drug Eluting Balloon for Peripheral Artery Disease Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 33. North America Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Country (2021–2032)

Figure 34. North America Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Country (2021–2032)

Figure 35. U.S. Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (US$ Million), 2021–2032

Figure 36. Canada Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (US$ Million), 2021–2032

Figure 37. Europe Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Country (2021–2032)

Figure 38. Europe Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Country (2021–2032)

Figure 39. Germany Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. France Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (US$ Million), 2021–2032

Figure 41. U.K. Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (US$ Million), 2021–2032

Figure 42. Italy Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (US$ Million), 2021–2032

Figure 43. Russia Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (US$ Million), 2021–2032

Figure 44. Asia Pacific Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Region (2021–2032)

Figure 45. Asia Pacific Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Region (2021–2032)

Figure 46. China Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (US$ Million), 2021–2032

Figure 47. Japan Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (US$ Million), 2021–2032

Figure 48. South Korea Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (US$ Million), 2021–2032

Figure 49. India Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (US$ Million), 2021–2032

Figure 50. Australia Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (US$ Million), 2021–2032

Figure 51. Taiwan Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (US$ Million), 2021–2032

Figure 52. Indonesia Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (US$ Million), 2021–2032

Figure 53. Thailand Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (US$ Million), 2021–2032

Figure 54. Malaysia Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (US$ Million), 2021–2032

Figure 55. Philippines Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (US$ Million), 2021–2032

Figure 56. Latin America Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Country (2021–2032)

Figure 57. Latin America Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Country (2021–2032)

Figure 58. Mexico Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (US$ Million), 2021–2032

Figure 59. Brazil Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (US$ Million), 2021–2032

Figure 60. Argentina Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (US$ Million), 2021–2032

Figure 61. Middle East and Africa Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Country (2021–2032)

Figure 62. Middle East and Africa Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Country (2021–2032)

Figure 63. Turkey Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (US$ Million), 2021–2032

Figure 64. Saudi Arabia Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (US$ Million), 2021–2032

Figure 65. U.A.E Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate (US$ Million), 2021–2032

Figure 66. Global Sales Market Share of Drug Eluting Balloon for Peripheral Artery Disease by Type (2021–2032)

Figure 67. Global Revenue Market Share of Drug Eluting Balloon for Peripheral Artery Disease by Type (2021–2032)

Figure 68. Global Drug Eluting Balloon for Peripheral Artery Disease Price (USD/Unit) by Type (2021–2032)

Figure 69. Global Sales Market Share of Drug Eluting Balloon for Peripheral Artery Disease by Application (2021–2032)

Figure 70. Global Revenue Market Share of Drug Eluting Balloon for Peripheral Artery Disease by Application (2021–2032)

Figure 71. Global Drug Eluting Balloon for Peripheral Artery Disease Price (USD/Unit) by Application (2021–2032)

Figure 72. Drug Eluting Balloon for Peripheral Artery Disease Value Chain

Figure 73. Channels of Distribution (Direct Vs Distribution)

Figure 74. Bottom-up and Top-down Approaches for This Report

Figure 75. Data Triangulation

Figure 76. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Drug Eluting Balloons DEB Market Insights Forecast to 2030

Paclitaxel Drug Eluting Balloon Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Peripheral Drug Eluting Stent Market Research Report 2025

Global Drug Eluting Peripheral Stents Market Research Report 2025

Drug Eluting Balloon Catheters Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Implantable Drug Eluting Stent Market Research Report 2024

Global Drug Eluting Balloon for Coronary Artery Disease Market Research Report 2025

Global Peripheral Drug eluting Balloon Market Research Report 2025

Global Peripheral Interventional Balloon Market Research Report 2024

Global Drug Coated Balloon for Peripheral Artery Diseases Market Research Report 2025

Global Implantable Coronary Drug Eluting Stent Market Research Report 2024

Global Peripheral Scoring Drug eluting Balloon Dilation Catheter Market Research Report 2024

Global Drug Eluting Coronary Stent System Market Research Report 2024

Drug Coated Balloon Catheter Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global PTA Drug Eluting Balloons Market Research Report 2025

Global Peripheral Balloon Expandable Stent Market Research Report 2024

Drug Eluting Stent System Market

Global Peripheral Intervention Drug Eluting Devices Market Insights Forecast to 2030

Global Peripheral DCB Catheter Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions